<!DOCTYPE html SYSTEM "about:legacy-compat">
<html class="no-js">
  <head>
    <meta charset="utf-8"/>
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1"/>
    <title>DC Code - § 3–1202.08. Board of Pharmacy and Advisory Committee on Clinical Laboratory Practitioners.</title>
    <meta property="st:title" content="§ 3–1202.08. Board of Pharmacy and Advisory Committee on Clinical Laboratory Practitioners."/>
    <meta name="description" content="A simple, free browser for the Washington, DC Code"/>
    <meta name="viewport" content="width=device-width"/>
    <link href="https://fonts.googleapis.com/css?family=Open+Sans:400italic,700italic,400,700" rel="stylesheet" type="text/css"/>
    <link rel="stylesheet" type="text/css" href="/css/main.css" media="screen"/>
    <link rel="stylesheet" type="text/css" href="/css/print.css" media="print"/>
    <script type="text/javascript">
            var _paq = _paq || [];
            _paq.push(['trackPageView']);
            _paq.push(['enableLinkTracking']);
            (function() {
              var u="//analytics.code.dccouncil.us/";
              _paq.push(['setTrackerUrl', u+'piwik.php']);
              _paq.push(['setSiteId', 1]);
              var d=document, g=d.createElement('script'), s=d.getElementsByTagName('script')[0];
              g.type='text/javascript'; g.async=true; g.defer=true; g.src=u+'piwik.js'; s.parentNode.insertBefore(g,s);
            })();

          window.searchHost = 'https://search.code.dccouncil.us';
          window.queryUrl = '/v1/search';
          </script>
    <noscript>
      <p>
        <img src="//analytics.code.dccouncil.us/piwik.php?idsite=1" style="border:0;" alt=""/>
      </p>
    </noscript>
  </head>
  <body>
    <header>
      <section class="container">
        <div class="right no-print search" id="search"> </div>
        <h1 id="sitename">
          <a href="/dc/council/code/">Code of the District of Columbia</a>
        </h1>
      </section>
    </header>
    <main class="main container">
      <div class="clearfix" style="width: 100%;">
        <aside id="sidebar" class="col4 quiet">
          <h2>You Are Here</h2>
          <ul class="ancestors">
            <li>↪ <a href="/">D.C. Law Library</a></li>
            <li>↪ <a href="/dc/council/code/">Code of the District of Columbia</a></li>
            <li>↪ <a href="/dc/council/code/titles/3/">Title 3. District of Columbia Boards and Commissions.</a></li>
            <li>↪ <a href="/dc/council/code/titles/3/chapters/12/">Chapter 12. Health Occupations Boards.</a></li>
            <li>↪ <a href="/dc/council/code/titles/3/chapters/12/subchapters/II/">Subchapter II. Establishment of Health Occupation Boards and Advisory Committees; Membership; Terms.</a></li>
            <li>↪ § 3–1202.08. Board of Pharmacy and Advisory Committee on Clinical Laboratory Practitioners.</li>
          </ul>
          <h2>Previous</h2>
          <p>
            <a href="/dc/council/code/sections/3-1202.07.html">§ 3–1202.07. Board of Optometry.</a>
          </p>
          <h2>Next</h2>
          <p>
            <a href="/dc/council/code/sections/3-1202.09.html">§ 3–1202.09. Board of Physical Therapy.</a>
          </p>
          <h2>Publication Information</h2>
          <h3>Current through Apr. 7, 2017</h3>
          <dl id="recency">
            <dt>Last codified D.C. Law:</dt>
            <dd>
          Law 21-265 effective Apr. 7, 2017</dd>
            <dt>Last codified Emergency Law:</dt>
            <dd>
          Act 21-354 effective Mar. 23, 2016</dd>
            <dt>Last codified Federal Law:</dt>
            <dd>
          Public Law  approved Dec. 14, 2016</dd>
          </dl>
          <section class="cta">
            <p>
              <a href="mailto:code@dccouncil.us?subject=[ERROR]+/dc/council/code/sections/3-1202.08.html">Report Error</a>
            </p>
            <p>
              <a href="mailto:code@dccouncil.us?subject=[FEEDBACK]+/dc/council/code/sections/3-1202.08.html">Website Feedback</a>
            </p>
            <p>We cannot respond to questions regarding the law.</p>
          </section>
        </aside>
        <section class="col8 body">
          <h1>§ 3–1202.08. Board of Pharmacy and Advisory Committee on Clinical Laboratory Practitioners.</h1>
          <section class="content">
            <section>
              <section class="line-group primary-content">
                <p class="text-indent-1"><span class="level-num" id="(a)">(a)</span> There is established a Board of Pharmacy to consist of 7 members appointed by the Mayor.</p>
                <p class="text-indent-1"><span class="level-num" id="(b)">(b)</span><span class="level-num" id="(b)(1)">(1)</span> The Board shall regulate the practice of pharmacy, the practice of pharmaceutical detailing, the practice of pharmacy technicians, and the practice of clinical laboratory practitioners with guidelines approved by the Advisory Committee on Clinical Laboratory Practitioners.</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(1A)">(1A)</span> The Board shall administer the examination required for cytotechnologists, histologic technicians, histotechnologists, medical laboratory technicians, and medical technologists.</p>
                <p class="text-indent-2"><span class="level-num" id="(b)(2)">(2)</span> The Board is authorized to:</p>
                <p class="text-indent-3"><span class="level-num" id="(b)(2)(A)">(A)</span> Establish a code of ethics for the practice of pharmaceutical detailing; and</p>
                <p class="text-indent-3"><span class="level-num" id="(b)(2)(B)">(B)</span> Collect information from licensed pharmaceutical detailers relating to their communications with licensed health professionals, or with employees or representatives of licensed health professionals, located in the District.</p>
                <p class="text-indent-1"><span class="level-num" id="(c)">(c)</span> Of the members of the Board, 5 shall be pharmacists licensed in the District and 2 shall be consumer members.</p>
                <p class="text-indent-1"><span class="level-num" id="(d)">(d)</span> Except as provided in subsection (e) of this section, members of the Board shall be appointed for terms of 3 years.</p>
                <p class="text-indent-1"><span class="level-num" id="(e)">(e)</span> Of the members initially appointed under this section, 2 shall be appointed for a term of 1 year, 2 shall be appointed for a term of 2 years, and 3 shall be appointed for a term of 3 years.</p>
                <p class="text-indent-1"><span class="level-num" id="(f)">(f)</span> An individual licensed to practice pharmacy pursuant to this chapter may administer immunizations and vaccinations only if certified to do so by the Board and only pursuant to a written protocol and valid prescription or standing order of a physician.</p>
                <p class="text-indent-1"><span class="level-num" id="(g)">(g)</span> The Board and the Board of Medicine shall jointly develop and promulgate regulations to implement and regulate the administration of vaccinations and immunizations by pharmacists and to authorize pharmacists certified to administer vaccinations and immunizations to administer emergency anaphylactic reaction treatment pursuant to an approved physician-pharmacist protocol.</p>
                <p class="text-indent-1"><span class="level-num" id="(h)">(h)</span><span class="level-num" id="(h)(1)">(1)</span> A licensed pharmacist may initiate, modify, or discontinue a drug therapy regimen pursuant to a collaborative practice agreement with a licensed physician, or, pursuant to § <a class="internal-link" href="/dc/council/code/sections/3-1204.12.html">3-1204.12</a>, other health practitioner.</p>
                <p class="text-indent-2"><span class="level-num" id="(h)(2)">(2)</span> The Board and the Board of Medicine shall jointly develop and issue regulations governing the implementation and use of collaborative practice agreements between a licensed pharmacist and a licensed physician. At minimum, the regulations shall:</p>
                <p class="text-indent-3"><span class="level-num" id="(h)(2)(A)">(A)</span> Require that all collaborative practice agreements include:</p>
                <p class="text-indent-4"><span class="level-num" id="(h)(2)(A)(i)">(i)</span> Specification of the drug therapy to be provided and any tests that may be necessarily incident to its provision;</p>
                <p class="text-indent-4"><span class="level-num" id="(h)(2)(A)(ii)">(ii)</span> The conditions for initiating, modifying, or discontinuing a drug therapy; and</p>
                <p class="text-indent-4"><span class="level-num" id="(h)(2)(A)(iii)">(iii)</span> Directions concerning the monitoring of a drug therapy, including the conditions that would warrant a modification to the dose, dosage regime, or dosage form of the drug therapy; and</p>
                <p class="text-indent-3"><span class="level-num" id="(h)(2)(B)">(B)</span> Establish policies and procedures for approving, disapproving, and revoking collaborative practice agreements.</p>
                <p class="text-indent-1"><span class="level-num" id="(i)">(i)</span> There is established an Advisory Committee on Clinical Laboratory Practitioners, which shall consist of 5 members appointed by the Mayor.</p>
                <p class="text-indent-1"><span class="level-num" id="(j)">(j)</span> The Advisory Committee on Clinical Laboratory Practitioners shall develop and submit to the Board guidelines for the licensure of cytotechnologists, histologic technicians, histotechnologists, medical laboratory technicians, medical technologists, and the registration of phlebotomists.</p>
                <p class="text-indent-1"><span class="level-num" id="(k)">(k)</span> Of the members of the Advisory Committee on Clinical Laboratory Practitioners, one shall be a pathologist certified by the American Board of Pathology or the American Board of Osteopathic Pathology; one shall be a medical technologist and supervisor; one shall be a medical technologist who is not a supervisor; one shall be a medical laboratory technician; and one shall be a consumer member with no direct affiliation with clinical laboratory practitioners or another health profession. Of the members of the Advisory Committee on Clinical Laboratory Practitioners, one shall be a pathologist certified by the American Board of Pathology or the American Board of Osteopathic Pathology; one shall be a medical technologist and supervisor; one shall be a medical technologist who is not a supervisor; one shall be a medical laboratory technician; and one shall be a consumer member with no direct affiliation with clinical laboratory practitioners or another health profession.</p>
                <p class="text-indent-1"><span class="level-num" id="(l)">(l)</span> The qualifications for the professional members of the Advisory Committee on Clinical Laboratory Practitioners shall be as follows:</p>
                <p class="text-indent-2"><span class="level-num" id="(l)(1)">(1)</span> The pathologist, for at least 3 years preceding appointment, shall have been actively engaged as a pathologist in rendering professional services in pathology or in the education and training of medical personnel in pathology.</p>
                <p class="text-indent-2"><span class="level-num" id="(l)(2)">(2)</span> The medical technologist, for at least 3 years preceding the appointment, shall have been actively engaged as a medical technologist in rendering professional services in medical technology or in the education and training of medical technologists.</p>
                <p class="text-indent-2"><span class="level-num" id="(l)(3)">(3)</span> The medical laboratory technician, for at least 3 years preceding the appointment, shall have been actively engaged as a medical laboratory technician in rendering professional services as a medical technician.</p>
                <p class="text-indent-1"><span class="level-num" id="(m)">(m)</span> The initial appointees of the Advisory Committee on Clinical Laboratory Practitioners, with the exception of the pathologist and the consumer representative, shall become licensed in the profession in which they have been practicing immediately upon their appointment and qualification as members of the Advisory Committee on Clinical Laboratory Practitioners.</p>
              </section>
              <br/>
              <section class="line-group annotations">
                <p>
      (<a class="internal-link" href="/dc/council/laws/6-99.html#§208">Mar. 25, 1986, D.C. Law 6-99, § 208, 33 DCR 729</a>; <a class="internal-link" href="/dc/council/laws/17-131.html">Mar. 26, 2008, D.C. Law 17-131, § 102(c), 55 DCR 1659</a>; <a class="internal-link" href="/dc/council/laws/17-306.html">Mar. 20, 2009, D.C. Law 17-306, § 2(b), 56 DCR 23</a>; <a class="internal-link" href="/dc/council/laws/19-185.html">Oct. 22, 2012, D.C. Law 19-185, § 2(b), 59 DCR 9454</a>; <a class="internal-link" href="/dc/council/laws/19-303.html">May 1, 2013, D.C. Law 19-303, § 2(b), 60 DCR 2711</a>; <a class="internal-link" href="/dc/council/laws/20-272.html">May 2, 2015, D.C. Law 20-272, § 2(c), 62 DCR 1911</a>.)
    </p>
                <h4>Prior Codifications</h4>
                <p>1981 Ed., § 2-3302.8.</p>
                <h4>Section References</h4>
                <p>This section is referenced in § <a class="internal-link" href="/dc/council/code/sections/1-523.01.html">1-523.01</a> and § <a class="internal-link" href="/dc/council/code/sections/3-1207.42.html">3-1207.42</a>.</p>
                <h4>Effect of Amendments</h4>
                <p><a class="internal-link" href="/dc/council/laws/17-131.html">D.C. Law 17-131</a> rewrote subsec. (b), which had read as follows: “(b) The Board shall regulate the practice of pharmacy.”</p>
                <p><a class="internal-link" href="/dc/council/laws/17-306.html">D.C. Law 17-306</a> added subsecs. (f) and (g).</p>
                <p>The 2012 amendment by <a class="internal-link" href="/dc/council/laws/19-185.html">D.C. Law 19-185</a> added (h).</p>
                <p>The 2013 amendment by <a class="internal-link" href="/dc/council/laws/19-303.html">D.C. Law 19-303</a> added “and the practice of pharmacy technicians” in (b)(1); and made a related change.</p>
                <p>The 2015 amendment by <a class="internal-link" href="/dc/council/laws/20-272.html">D.C. Law 20-272</a> rewrote the section heading; rewrote (b)(1); added (b)(1A); and added (i), (j), (k), (l), and (m).</p>
                <h4>Emergency Legislation</h4>
                <p>For temporary (90 day) amendment of section, see § 2(b) of Pharmacy Practice Emergency Amendment Act of 2008 (D.C. Act 17-596, December 8, 2008,  55 DCR 12816).</p>
                <p>For temporary (90 day) amendment of section, see § 2(b) of Pharmacy Practice Congressional Review Emergency Amendment Act of 2009 (D.C. Act 18-29, March 16, 2009,  56 DCR 2323).</p>
              </section>
            </section>
          </section>
        </section>
      </div>
    </main>
    <footer>
      <section class="container center">
        <p>The codes and laws on this website are in the public domain.</p>
        <p>
              Please do not scrape. Instead, bulk download the <a href="https://github.com/dccouncil/dc-law-html">HTML</a> or <a href="https://github.com/dccouncil/dc-law-xml">XML</a>.
            </p>
        <p>Powered by the non-profit <a href="http://www.openlawlib.org/">Open Law Library</a>.</p>
      </section>
    </footer>
    <script type="text/javascript" src="/js/main.js"> </script>
  </body>
</html>
